Literature DB >> 1323547

Evaluation of an intensive weight control program using a priori criteria to determine outcome.

D Beliard1, D S Kirschenbaum, M L Fitzgibbon.   

Abstract

This study evaluated the effectiveness of a comprehensive obesity treatment program which incorporated open-ended treatment duration, pre-treatment assessments, protein-sparing modified fasts (PSMFs), and the use of six a priori outcome categories to analyse outcomes. Subjects were the first 291 obese individuals (mean weight = 235 lb, 66% overweight) to participate in the program's intake procedures. Data obtained after 55 weeks of treatment (on average) showed that the program seemed quite effective for 65% of those who participated for at least 12 weeks (mean = 62 and 30 lb lost in the two successful groups). Analyses supported the continued use of pre-treatment assessments, extended treatment times, and a priori categorizations of outcomes. In addition, correlational analyses showed that binge eating, high levels of psychological distress, and low income levels were associated with poorer outcomes.

Entities:  

Mesh:

Year:  1992        PMID: 1323547

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  3 in total

1.  Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study.

Authors:  Jian-Ping Zhang; Jeffrey J Weiss; Melissa McCardle; Hope Klopchin; Eileen Rosendahl; Lawrence Maayan; Antonio Convit; John M Kane; Peter Manu; Christoph U Correll
Journal:  J Clin Psychopharmacol       Date:  2012-08       Impact factor: 3.153

Review 2.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 3.  Behavioral management of obesity.

Authors:  Craig A Johnston; Chermaine Tyler; John P Foreyt
Journal:  Curr Atheroscler Rep       Date:  2007-12       Impact factor: 5.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.